Table 4. Toxicity profile of selected aza compounds (1-6).
| Toxicity | |||||||
| Compound | aLD50 (mg/kg) | Class | HEPATOTOXICITY | CARCINOGENICITY | IMMUNOTOXICITY | MUTAGENICITY | CYTOTOXICITY |
| 1 | 6600 | 6 | Inactive | Active | Inactive | Inactive | Inactive |
| 2 | 6600 | 6 | Inactive | Active | Inactive | Inactive | Inactive |
| 3 | 6600 | 6 | Inactive | Active | Inactive | Inactive | Inactive |
| 4 | 6600 | 6 | Inactive | Active | Inactive | Inactive | Inactive |
| 5 | 6600 | 6 | Inactive | Active | Inactive | Inactive | Inactive |
| 6 | 6600 | 6 | Inactive | Inactive | Inactive | Inactive | Inactive |
| Amoxicillin | 15000 | 6 | Inactive | Inactive | Inactive | Inactive | Inactive |
| Moxifloxacin | 2000 | 4 | Inactive | Inactive | Inactive | Active | Inactive |
| Sulfanilamide | 3000 | 5 | Inactive | Active | Inactive | Inactive | Inactive |
| Sulfamethoxazole | 2300 | 5 | Active | Active | Inactive | Inactive | Inactive |
| aLD50: lethal dose parameter |